EU Parkinsons Disease Treatment Market Expected to Grow Faster According to New Research Report 2023-2028

The EU Parkinsons Disease Treatment Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global EU Parkinsons Disease Treatment market. This report explores all the key factors affecting the growth of the global EU Parkinsons Disease Treatment market, including demand-supply scenario, pricing structure, profit margins, production, and value chain analysis.

Get PDF Sample Report Now! @ https://www.prudentmarkets.com/sample-request/141763/

Report Description of the EU Parkinsons Disease Treatment Market Analysis

Research Scope and Assumption

The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
Inflation has not been accounted for in order to estimate and forecast the market
Numbers may not add up due to rounding off

Reason to buy the report:

Facilitate decision-making based on strong current and forecast data for EU Parkinsons Disease Treatment Market Analysis
Develop strategies based on the latest regulatory framework
Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the EU Parkinsons Disease Treatment Market Analysis
Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
To strategically profile key players and comprehensively analyze their market shares and core competencies
We have technically sound team which do a deep dive research and also provide strategy based consulting analysis

EU Parkinsons Disease Treatment Market Analysis Executive Summary

Parkinson's disease is termed as a progressive neurodegenerative disorder that affects dopaminergic neurons in the brain. Parkinson's disease mainly causes tremors, muscle stiffness, abnormal movement, walking, and balance problems. Secondary symptoms of this ailment include anxiety, depression, and dementia. The exact etiology of Parkinson's disease is unknown and mainly affects older people over the age of 50, but men suffer half of the women's illnesses. According to estimates by the United States Parkinson Foundation, the disease affects about 70 to 10 million people worldwide, and about 50,000 Americans are diagnosed with the disease each year. In developed regions like Europe, the high prevalence and risk of this disease are driving the growth of the Parkinson's disease treatment market.

Market Size and Key Findings

The EU Parkinsons Disease Treatment Market Analysis size stood at around USD 1.4 billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 5.88% during the forecast period.

The size of the Europe Parkinson's Disease Treatment Market was worth USD 1.4 billion in 2020 and estimated to be growing at a CAGR of 5.88% by 2028.

Market Dynamics

Market Growth Drivers Analysis

Parkinson's Disease Treatment market propels with a growing public understanding of this disease, the multiplying elderly population, the prospect of launching pipeline drugs and new products, and relatively high growth in the therapeutic market. The government and non-profit organizations understanding of Parkinson's disease and higher clinical research and development budgets are expected to drive the growth of the Parkinson's treatment market over the forecast period. Promising product channels represent potential business development opportunities over the projection period.

Market Restraints

It is expected that the patent expiry of crucial drugs and side effects related to therapeutic medicines will limit the growth of Europe's Parkinson's disease treatment market over the forecast period.

COVID-19 impact on EU Parkinsons Disease Treatment Market

People with Parkinsons disease face a higher risk of dying from Covid-19 and studies have also indicated that the conditions created by the pandemic have impacted sleep disturbances and medication access for many of those living the condition. The immediate negative consequences of the COVID-19-period for People with Parkinsons disease (PwP) may not be as severe as expected. Conversely, patient ratings and free-text descriptions suggest that, despite increased anxiety, the pandemic and related changes in society are associated with improvement in Health-Related Quality of Life (HRQL), better night sleep and an overall feeling that the pressure is gone.

Competitive Landscape

Key Players

Leading companies dominating the European Parkinson's Disease Treatment Market profiled in this report are Teva (Israel), Novartis AG (Switzerland), GSK (UK), AbbVie (US), Merck (US). Boehringer Ingelherm (Germany), Impax Laboratories (US), Lundbeck (Denmark), Sun Pharma (India), Wockhardt (India), UCB (Belgium), Valeant Pharmaceuticals (Canada), and Acadia (US).

Products in Pipeline

According to the Parkinson's Disease Clinic and Research Center, University of California, US, gene therapy for Parkinsons disease has shown promising results in phase I studies. Phase II and III studies are currently under progress. Surgical treatments, restriction on the use of medications in severe stages of the disease, and the increased focus on gene therapy research are expected to restrain the demand for therapeutic drugs used in Parkinsons disease.

Notable Recent Deals

In 2016, ACADIA Pharmaceuticals, Inc. (U.S.) received FDA approval for its NUPLAZID drug.
In 2016, Sun Pharmaceutical Industries Ltd. (India) entered distribution agreement with Mitsubishi Tanabe Pharma Corporation (Japan) to distribute 14 prescription brands that include Parkinsons disease drug Parlodel in Japan.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario

The European Parkinsons Disease Association (EPDA) is the only European Parkinsons Umbrella Organization. We have been championing and working with the global Parkinsons community for nearly 30 years. Since the EPDA was founded, back in 1992, their focus has always been 100% on collaboration and building unity across Europe and the world. While national Organizations work on national agendas in their own countries, we strive to unite the international Parkinsons community to work together to achieve common goals and to pursue the EPDA vision: to enable all people with Parkinsons to live a full life, while supporting the search for a cure.

To Know More About COVID-19 Impact On EU Parkinsons Disease Treatment Market @ https://www.prudentmarkets.com/sample-request/141763/

EU Parkinson's Disease Treatment Market Analysis Segmentation

By Drug Class:

On the basis of drug class, the market is segmented into Carbidopa/Levodopa, Dopamine Receptor Agonists, MAO-inhibitors, Anticholinergics and other drugs. The Carbidopa/Levodopa segment is expected to account for the largest share of the market in 2017. The growth in this segment is primarily attributed to the potency of the drug.

By Distribution Channel:

By distribution channel, the market is segmented into hospital pharmacies, retailer pharmacies, and online pharmacies. In 2017, the hospital pharmacies segment accounted for the largest share of the market. Increasing number of patient visits to the hospital due to the availability of diagnostic laboratories and presence of skilled neurologists are driving the growth of hospital pharmacies segment.

By Patient Care Setting:

On the basis of patient care setting, the Parkinson's disease treatment market is segmented into hospitals and clinics. In 2017, hospitals are expected to account for the largest share of the market. Robust health infrastructure and presence of skilled neurologists are the driving factors for hospital segment.

By Country:

Regionally, Europe is supposed to gain the largest share of the global Parkinson's disease treatment market, followed by North America, and its market share is also considerable. Understanding of treatment, increased expenditure on research and development, favorable drug reimbursement regulations and policies, high incidence of Parkinson's disease, the rapid increase in the elderly population, and potential medical pipeline products may account for a significant share of the Europe Parkinson's disease treatment market. The regional market is foreseen to grow at a reasonable rate. The most critical market share in the European Parkinson's disease treatment market may be occupied by nations like the UK, Germany, France, etc., mainly due to a large number of patients with Parkinson's disease in these countries.

Prudent Markets provides attractive discounts that fit your needs. Customization of the reports as per your requirement is also offered. Get in touch with our sales team, who will guarantee you a report that suits your needs.

Speak To Our Analyst For A Discussion On The Above Findings, And Ask For A Discount On The Report @ https://www.prudentmarkets.com/discount-request/141763/

The report covers the competitive analysis of the market. As the demand is driven by a buyer's paying capacity and the rate of item development, the report shows the important regions that will direct growth. This section exclusively shares insight into the budget reports of big-league members of the market helping key players and new entrants understand the potential of investments in the Global EU Parkinsons Disease Treatment Market. It can be better employed by both traditional and new players in the industry for complete know-how of the market.

Strategic Points Covered in Table of Content of Global EU Parkinsons Disease Treatment Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the EU Parkinsons Disease Treatment market
Chapter 2: Exclusive Summary - the basic information of the EU Parkinsons Disease Treatment Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the EU Parkinsons Disease Treatment
Chapter 4: Presenting the EU Parkinsons Disease Treatment Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country
Chapter 6: Evaluating the leading manufacturers of the EU Parkinsons Disease Treatment market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Any Questions? Feel Free To Enquire Here. We Will put you on the Right Path @ https://www.prudentmarkets.com/enquiry-request/141763/

Free Customization on the basis of client requirements on Immediate purchase:
1- Free country-level breakdown of any 5 countries of your interest.
2- Competitive breakdown of segment revenue by market players.

Customization of the Report:
This report can be customized to meet the client's requirements. Please connect with our sales team (sales@prudentmarkets.com), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +91 83560 50278 || USA/Canada(Toll Free): 1800-601-6071 to share your research requirements.

Get ready to Recognize the pros and cons of the regulatory framework, local reforms, and its effect on the Industry. Understand how the Leaders in Intelligent Network are keeping themselves one stage forward with our most up-to-date survey analysis.

In conclusion, the EU Parkinsons Disease Treatment Market report is a genuine source for accessing the research data which is projected to exponentially grow your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rates, and figures. SWOT analysis and PESTLE analysis is also incorporated in the report.

Contact Us:
Allan Carter
Andheri, Maharashtra, 400102
USA/Canada(Toll Free): 1800-601-6071
Direct Line: +91 83560 50278
Mail: sales@prudentmarkets.com
Web: www.prudentmarkets.com

About Us:
We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy.

This release was published on openPR.